THEUER CHARLES 4
4 · Tracon Pharmaceuticals, Inc. · Filed Apr 28, 2023
Insider Transaction Report
Form 4
THEUER CHARLES
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2023-04-27$0.75/sh+47,000$35,250→ 399,417 total - Purchase
Common Stock
2023-04-26$0.66/sh+3,999$2,639→ 352,417 total
Footnotes (2)
- [F1]Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.72 to $0.7596, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.